Prilenia signs deal for former Teva ALS drug worth up to 500m
Israeli-Dutch scientific stage biotech firm Prilenia Therapeutics has introduced a collaboration and licensing settlement for its lead drug Pridopidine, ...
Saturday, June 20, 2026
Tag: ALS
NeuroSense schedules FDA meeting for ALS drug trial By Investing.com
CAMBRIDGE, Mass. - NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a biotech agency specializing in neurodegenerative illness therapies, has secured a Kind ...
RECOMMENDED
Investors ‘reluctant’ to splash cash on UK banks amid crisis in No10
Monday 15 June 2026 1:45 pm Banks could possibly be 'entrance and centre' in a brand new authorities. (Picture: PA)...
Copyright © 2024 PWC.